Please login to the form below

Not currently logged in
Email:
Password:

Verona names David Ebsworth as non-executive chairman

He joins from Vifor Pharma
Verona names David Ebsworth as non-executive chairman

Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors.

Ebsworth's role will be effective from December 1 when he will take over from Prof Clive Page, who has held the position since founding the company in 2006.

Ebsworth (pictured) is an experienced pharma executive who has worked at board and senior management level at a number of international companies. He most recently served as CEO at Vifor Pharma and was also named CEO of Galenica in 2011, continuing to be an adviser for both firms.

His career in the pharma industry spans over 35 years, including a 19-year stint at Bayer where he worked up through the company from product manager to general manager of the global pharma division.

Commenting on his appointment, Ebsworth said: “I am looking forward to working closely with Verona Pharma's board and management to guide the company towards success. I shall use my background and experience in both international pharma and biotech to support this innovative company within the hugely rewarding respiratory space.”

Dr Jan-Anders Karlsson, CEO of Verona Pharma, said: “We thank Clive for all his achievements as we welcome David to the board. David' significant expertise in the pharma industry strongly supports Verona Pharma's focus on high value commercial opportunities and future growth.”

24th November 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics